Exelixis
EXEL
#1569
Rank
C$19.79 B
Marketcap
C$78.77
Share price
0.79%
Change (1 day)
29.20%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company